li zhu-凯发k8娱乐

• 2001.9-2005.6   兰州大学生命科学学院，国家基础人才培养基地班，获学士学位；
• 2005.9-2011.6   兰州大学生命科学学院生物物理研究所，获博士学位；
• 2011.8-2014.12  美国纽约州卫生部沃兹沃斯研究中心（new york state department of health, wadsworth center），post-doctoral research affiliate。

主持国家自然科学基金青年基金1项；

主持教育部中央高校基本科研业务费面上项目1项；

参与国家自然科学基金3项。

● zhao j, zhu l, fan c, wu y, xiang s, structure and function of urea amidolyase. biosci rep., 2018 jan 17;38(1). pii: bsr20171617. doi: 10.1042/bsr20171617.

● xiong j, liu x, gong y, zhang p, qiang s, zhao q, guo r, qian y, wang l, zhu l, wang r, hao z, wen h, zhang j, tang k, zang wf, yuchi z, chen h, wayne chen sr, zheng w, wang sq, xu yw, liu z., pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel ryr2, j mol cell cardiol,2018, 117: 26-35 (2016 if 5.68).

● yan ouyang, li zhu*, yifang li, miaomiao guo, yang liu, jin cheng, jing zhao, yi wu^*, architectural plasticity of ampk revealed by electron microscopy and x-ray crystallography, scientific reports, 2016, 6:24191, doi: 10.1038/srep24191 (co-corresponding author) (2016 if 4.259)

● zhu li^#, zhong xiaowei, chen s r wayne, banavali nilesh, liu zheng^*, modeling a ryanodine receptor n-terminal domain connecting the central vestibule and the corner clamp region, journal of biological chemistry, 2013, 288(2): 903-914 (5-year if 4.863)

● zhong xiaowei^#, liu ying^#, zhu li^#, meng xing, wang ruiwu, van petegem filip, wagenknecht terence, chen s r wayne, liu zheng^*, conformational dynamics inside amino-terminal disease hotspot of ryanodine receptor, structure, 2013, 21(11): 2051-2060 (co-first author) (5-year if 6.337)

● zhu li^#, chen lei, zhou xiao-ming, zhang yuan-yuan, zhang yi-jiong, zhao jing, ji shang-rong, wu jia-wei^*, wu yi^*, structural insights into the architecture and allostery of full-length amp-activated protein kinase, structure, 2011, 19(4): 515-522 (5-year if 6.337)

● ji s.-r., wu y.^*, zhu l., potempa l.a., sheng f.-l., lu w., zhao j. (2007) cell membranes and liposomes dissociate c-reactive protein (crp) to form a new, biologically active structural intermediate: mcrpm. faseb j, 21(1): 284-294. (5-year if 6.045)